What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Acquired immunodeficiency syndrome
- Cancer
John Bartlett focuses on Immunology, Internal medicine, Virology, Acquired immunodeficiency syndrome and Pathology.
John Bartlett has included themes like Odds ratio, Drug resistance and Nevirapine in his Immunology study.
The Internal medicine study combines topics in areas such as Gastroenterology and Viral load.
His work on Retinite as part of his general Virology study is frequently connected to Azole, thereby bridging the divide between different branches of science.
His Sida study in the realm of Acquired immunodeficiency syndrome interacts with subjects such as In patient.
The concepts of his Pathology study are interwoven with issues in Antimicrobial and Medical emergency.
His most cited work include:
- Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection: A Controlled Trial in Persons with Fewer Than 500 CD4-Positive Cells per Cubic Millimeter (1086 citations)
- Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. (628 citations)
- Extra-intestinal manifestations of salmonella infections. (494 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Immunology, Virology, Acquired immunodeficiency syndrome and Tanzania.
John Bartlett is studying Randomized controlled trial, which is a component of Internal medicine.
His work deals with themes such as Nevirapine and Drug resistance, which intersect with Immunology.
His biological study focuses on Virus.
His Acquired immunodeficiency syndrome study which covers Viral disease that intersects with Immunopathology.
Cross-sectional study, Family medicine, Pediatrics, Voluntary counseling and testing and Nursing are fields of study that overlap with his Tanzania research.
He most often published in these fields:
- Internal medicine (29.12%)
- Immunology (23.15%)
- Virology (17.66%)
What were the highlights of his more recent work (between 2013-2021)?
- Tanzania (17.18%)
- Internal medicine (29.12%)
- Family medicine (11.93%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Tanzania, Internal medicine, Family medicine, Medical education and Cross-sectional study.
His research integrates issues of Immunology and Oncology in his study of Internal medicine.
His study in Immunology is interdisciplinary in nature, drawing from both Regimen, Cervical cancer and Drug resistance.
John Bartlett has included themes like Odds ratio, Health care and Regional cancer in his Family medicine study.
His work deals with themes such as Cancer screening and Acquired immunodeficiency syndrome, which intersect with Health care.
His research in Cross-sectional study intersects with topics in Cancer and Interquartile range.
Between 2013 and 2021, his most popular works were:
- Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. (628 citations)
- Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas (327 citations)
- Genomic and Functional Approaches to Understanding Cancer Aneuploidy (296 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Acquired immunodeficiency syndrome
His primary areas of investigation include Cancer research, Pediatrics, Internal medicine, Tanzania and Antiretroviral therapy.
His Cancer research study combines topics in areas such as Chromatin, Transcription factor, Gene and microRNA.
His Pediatrics study integrates concerns from other disciplines, such as Cross-sectional study, Delayed diagnosis, Cohort study and Kaposi's sarcoma.
John Bartlett works on Internal medicine which deals in particular with Confidence interval.
He interconnects Second line, First line, Health care and Referral in the investigation of issues within Antiretroviral therapy.
John Bartlett combines subjects such as Discontinuation, Relative risk, Randomized controlled trial, Reverse-transcriptase inhibitor and Efavirenz with his study of Ritonavir.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
